|
Volumn 22, Issue 5, 2009, Pages 283-
|
Molecule of the month: catumaxomab.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BISPECIFIC ANTIBODY;
CATUMAXOMAB;
CELL ADHESION MOLECULE;
TUMOR ANTIGEN;
TUMOR ASSOCIATED ANTIGEN GA733;
TUMOR-ASSOCIATED ANTIGEN GA733;
ARTICLE;
ASCITES;
DRUG EFFECT;
HUMAN;
METABOLISM;
PATHOPHYSIOLOGY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
ANTIBODIES, BISPECIFIC;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
ASCITES;
CELL ADHESION MOLECULES;
CLINICAL TRIALS, PHASE II AS TOPIC;
CLINICAL TRIALS, PHASE III AS TOPIC;
HUMANS;
|
EID: 70449728456
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: 10.1358/dnp.2009.22.5.1380250 Document Type: Article |
Times cited : (1)
|
References (0)
|